Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:32:51-82.
doi: 10.1146/annurev-immunol-032713-120257. Epub 2013 Dec 2.

TGF-β activation and function in immunity

Mark A Travis  1 , Dean Sheppard
Affiliations
Review

TGF-β activation and function in immunity

Mark A Travis et al. Annu Rev Immunol. 2014.

Abstract

The cytokine TGF-β plays an integral role in regulating immune responses. TGF-β has pleiotropic effects on adaptive immunity, especially in the regulation of effector and regulatory CD4(+) T cell responses. Many immune and nonimmune cells can produce TGF-β, but it is always produced as an inactive complex that must be activated to exert functional effects. Thus, activation of latent TGF-β provides a crucial layer of regulation that controls TGF-β function. In this review, we highlight some of the important functional roles for TGF-β in immunity, focusing on its context-specific roles in either dampening or promoting T cell responses. We also describe how activation of TGF-β controls its function in the immune system, with a focus on the key roles for members of the integrin family in this process.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Synthesis and processing of TGF-β isoforms into small and large latent complexes. TGF-β genes encode an N-terminal latency-associated peptide (LAP) and a C-terminal mature cytokine that form dimeric structures. The LAP and the mature TGF-β cytokine are cleaved from each other by the enzyme furin but remain noncovalently associated. The LAP region folds around the mature cytokine, blocking access of TGF-β to its receptor, and is termed the small latent complex. In the LAP of TGF-β1 and 3 (but not TGF-β2) there is an arginine-glycine-aspartic acid (RGD) site that facilitates binding to integrins. In some cells, the small latent complex can associate with latent TGF-β binding protein (LTBP) via interactions with LAP, forming the large latent complex. LTBP can facilitate binding of the large latent complex to proteins of the extracellular matrix.
Figure 2
Figure 2
Signaling pathways triggered by TGF-β. Active TGF-β binds to a dimer of TGF-βRII, which associates with a dimer of TGF-βRI to form a tetrameric receptor complex. TGF-βRII then phosphorylates the cytoplasmic domain of TGF-βRI, which activates the kinase activity of TGF-βRI. TGF-βRI can then associate with and phosphorylate receptor Smads (Smad2 or 3), which subsequently form a complex with either Smad4 or TIF1γ. The activated Smad complexes then act to modulate gene expression by binding to Smad-responsive elements in genes. TGF-β receptor activation can also trigger non-Smad-mediated signaling events (e.g., via MAPK, Rho GTPases, or PI3 kinase) to regulate gene expression.
Figure 3
Figure 3
Regulation of multiple CD4+ T cell phenotypes by TGF-β. The latent complex of TGF-β must be activated to function, and recent data highlight a key role for integrin αvβ6 expressed by epithelial cells and integrin αvβ8 expressed by dendritic cells in activating TGF-β. Once activated, TGF-β performs important functions in controlling both anti-inflammatory and proinflammatory T cell responses, with the presence of other cytokines dictating the functional outcome of TGF-β signaling in T cells.
Figure 4
Figure 4
Latent TGF-β can be activated by integrins via generation of physical force. Physical force generated by contraction of the actin cytoskeleton of cells expressing certain TGF-β-activating integrins (e.g., αvβ6) unfolds the unstructured region (straitjacket) of the latency-associated peptide that forms the major contact points with the active TGF-β dimer, thereby releasing active TGF-β and freeing it to interact with TGF-β receptors. Integrins αvβ3 and αvβ5 are proposed to activate latent TGF-β via a similar mechanism (not shown). Adapted from Reference and reprinted with permission from Nature Publishing Group and Prof. Timothy Springer (Harvard University).
Figure 5
Figure 5
Th17 cell induction via dendritic cell (DC)–expressed, integrin αvβ8–mediated TGF-β activation requires MHC-II–antigen–TCR interaction. (a) Activation of TGF-β by integrin αvβ8 expressed by DCs, in the presence of proinflammatory cytokines, can induce Th17 cell differentiation when the DC presents antigen via MHC-II to naive T cells. (b) In the absence of integrin αvβ8 expression, DCs are unable to induce Th17 cell differentiation. Additionally, DCs that express integrin αvβ8 but express a mismatched haplotype of MHC-II that cannot present antigen to T cells cannot induce Th17 cells.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, et al. TGF-β latency: biological significance and mechanisms of activation. Stem Cells. 1997;15:190–97. - PubMed
    1. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int. 1997;51:1376–82. - PubMed
    1. Pesu M, Watford WT, Wei L, Xu L, Fuss I, et al. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature. 2008;455:246–50. - PMC - PubMed
    1. Shi M, Zhu J, Wang R, Chen X, Mi L, et al. Latent TGF-β structure and activation. Nature. 2011;474:343–49. - PMC - PubMed
    1. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFβ activation. J Cell Sci. 2003;116:217–24. - PubMed

Publication types